Cure My Disease

Don't miss your cure!

 Log in / Sign up

New supplement cocktail aims to stop preterm labor

NCT ID NCT07305519

Recruiting now Prevention Sponsor: University of Roma La Sapienza Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a daily supplement containing magnesium, palmitoylethanolamide, high-molecular-weight hyaluronic acid, vitamin B6, and vitamin D can help prevent preterm birth in women at risk. The supplement is given alongside standard vaginal progesterone. The trial will enroll 150 pregnant women with a short cervix (between 15 and 30 mm) and follow them until delivery to see if the combination reduces births before 37 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a combination oral supplement containing magnesium, palmitoylethanolamide, high-molecular-weight hyaluronic acid, vitamin B6, and vitamin D, plus vaginal progesterone
What this could lead to
If it works, this could offer a simple, safe supplement-based way to reduce the risk of preterm birth in women with a short cervix.
What could go wrong
This is a relatively small, early-stage trial (150 participants) and the supplement is added to standard care, so any added benefit may be modest. Results may not apply to all at-risk women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM LABOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obstetric Labor, Premature Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRETERM LABOR

Contacts and locations

Locations

  • Policlinico Umberto I

    RECRUITING

    Rome, RM, 00161, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.